Devices › Permanent pacemaker electrode
Device brand name · Bipolar epicardial lead
Myopore Sutureless Myocardial Pacing Lead 54 Cm: medical device reports filed with FDA
221 reports name it, 2015–2022. Manufacturer given most often on reports: Greatbatch Medical. Product code DTB.
- 221
- device reports naming the brand
- 0% of all MAUDE reports · about 19 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 44.3%
- classified as malfunction
- 43.9% across the product code
- 2.3%
- classified as death, as reported
- 5 reports · not verified by FDA
FDA's MAUDE database holds 221 reports that name the brand "Myopore Sutureless Myocardial Pacing Lead 54 Cm" (bipolar epicardial lead), received between January 2015 and December 2022; the manufacturer given most often on reports is Greatbatch Medical. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (52.9%), malfunction (44.3%) and death (2.3%); across all permanent pacemaker electrode reports (product code DTB) death is recorded in 2.9% and malfunction in 43.9%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to capture (22.2%), high capture threshold (7.2%) and insufficient device problem information (4.5%). The patient problems coded most often are therapeutic response, decreased, bacterial infection and sepsis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 327,317 reports carrying product code DTB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to capture | 49 | 22.2% | 9.7% |
| High capture threshold | 16 | 7.2% | 12.3% |
| Insufficient device problem information | 10 | 4.5% | 1% |
| High impedance | 8 | 3.6% | 10.7% |
| Fracturea broken bone | 5 | 2.3% | 4.8% |
| Pacing problem | 5 | 2.3% | 5% |
| Capturing problem | 3 | 1.4% | 4.2% |
| High sensing threshold | 3 | 1.4% | 2.3% |
| Low impedance | 3 | 1.4% | 5.3% |
| Device dislodged or dislocated | 2 | 0.9% | 9.1% |
| Device sensing problem | 2 | 0.9% | 1.9% |
| Migrationthe device moved from where it was placed | 2 | 0.9% | 0% |
| Over-sensing | 2 | 0.9% | 13.2% |
| Device operates differently than expectedthe device behaved unexpectedly | 1 | 0.5% | 0.4% |
| Extracardiac stimulation | 1 | 0.5% | 0.5% |
| Improper or incorrect procedure or method | 1 | 0.5% | 0% |
| Loss of threshold | 1 | 0.5% | 0.7% |
| Positioning problem | 1 | 0.5% | 2.2% |
| Therapeutic or diagnostic output failure | 1 | 0.5% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Therapeutic response, decreased | 63 | 28.5% |
| Bacterial infectiona bacterial infection | 36 | 16.3% |
| Sepsisa severe body-wide response to infection | 10 | 4.5% |
| Erosion | 7 | 3.2% |
| Cardiac perforation | 3 | 1.4% |
| Deaththe patient died; cause not stated by this term | 3 | 1.4% |
| Pericardial effusionfluid around the heart | 3 | 1.4% |
| Chest painchest pain | 2 | 0.9% |
| Dyspneashortness of breath | 2 | 0.9% |
| Muscle stimulation | 2 | 0.9% |
| Syncopefainting | 2 | 0.9% |
| Tachycardiafast heart rate | 2 | 0.9% |
| Bradycardiaslow heart rate | 1 | 0.5% |
| Cardiac arrestthe heart stopped | 1 | 0.5% |
| Hemoptysis | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Myopore Sutureless Myocardial Pacing Lead 54 Cm | Product code DTB | All MAUDE reports |
|---|---|---|---|
| Reports | 221 | 327,317 | 26,136,888 |
| Share of that pool | — | 0.1% | 0% |
| Classified as death, per 1,000 reports | 23 | 29 | 9 |
| Classified as injury | 52.9% | 53.1% | 36.2% |
| Classified as malfunction | 44.3% | 43.9% | 62.3% |
| Filed by the manufacturer | 100% | 96.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DTB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| CapSureFix Novus Lead MRI SureScan | 108,103 | 17,554 | 1% |
| Capsurefix Novus | 57,538 | 4 | 6.8% |
| CapSureFix Novus MRI SureScan | 18,909 | 3,243 | 1.3% |
| CapSure Sense Lead MRI SureScan | 8,774 | 1,337 | 1% |
| CapSure SP | 8,223 | 226 | 3.9% |
| Capsurefix | 7,284 | 0 | 6.3% |
| Permanent Pacemaker Electrode | 5,041 | 332 | 0.4% |
| Capsure Sp Novus | 4,803 | 0 | 9.5% |
| Capsure Sense | 4,740 | 0 | 6.4% |
| Flextend | 6,836 | 203 | 0.7% |
| Attain Otw | 7,773 | 0 | 9.1% |
| Tendril Sdx | 8,316 | 3 | 2.3% |
| CapSure Epicardial Lead | 4,842 | 760 | 1.5% |
| Tendril Sts | 54,036 | 4,320 | 3.1% |
| CapSure SP Novus Lead | 2,715 | 331 | 1.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Myopore Sutureless Myocardial Pacing Lead 54 Cm reports
How many FDA reports name Myopore Sutureless Myocardial Pacing Lead 54 Cm?
221 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (52.9%), malfunction (44.3%) and death (2.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to capture (22.2%), high capture threshold (7.2%), insufficient device problem information (4.5%), high impedance (3.6%) and fracture (2.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Myopore Sutureless Myocardial Pacing Lead 54 Cm was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.